The influence of previous exposure to environmental mycobacteria on the interferon-gamma response to bacille Calmette-Guérin vaccination in southern England and northern Malawi

Clinical and Experimental Immunology

Volumn 146, Issue 3, 2006, Pages 390-399

  Weir, R E ^a   Black, G F ^a,b,e   Nazareth, B ^c,d   Floyd, S ^a   Stenson, S ^a   Stanley, C ^a   Branson, K ^a   Sichali, L ^b   Chaguluka, S D ^b   Donovan, L ^b   Crampin, A C ^a,b   Fine, P E M ^a   Dockrell, H M ^a  

^a LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^b KARONGA PREVENTION STUDY   (Malawi)

^c Redbridge and Waltham Forest Health Authority   (United Kingdom)

^d Cambridgeshire and Peterborough Public Health Protection Unit   (United Kingdom)

^e STELLENBOSCH UNIVERSITY   (South Africa)

Author keywords

BCG; English schoolchildren; Environmental mycobacteria; IFN ; Malawi; Tuberculosis vaccine

Indexed keywords

BCG VACCINE; GAMMA INTERFERON; MYCOBACTERIUM ANTIGEN; TUBERCULIN;

ARTICLE; BCG VACCINATION; CELLULAR IMMUNITY; CONTROLLED STUDY; CROSS REACTION; CYTOKINE PRODUCTION; DRUG EFFECT; ENVIRONMENTAL EXPOSURE; HUMAN; IMMUNE SYSTEM; LUNG TUBERCULOSIS; MAJOR CLINICAL STUDY; MALAWI; MYCOBACTERIUM BOVIS; MYCOBACTERIUM TUBERCULOSIS; PREVALENCE; PRIORITY JOURNAL; SCHOOL CHILD; SPECIES DIFFERENCE; UNITED KINGDOM;

ADOLESCENT; ANTIGENS, BACTERIAL; BCG VACCINE; CROSS REACTIONS; ENGLAND; FEMALE; HUMANS; INTERFERON TYPE II; MALAWI; MALE; MYCOBACTERIUM; MYCOBACTERIUM INFECTIONS; SPECIES SPECIFICITY; TUBERCULIN; VACCINATION;

EID: 33750874082     PISSN: 00099104     EISSN: 13652249     Source Type: Journal    
DOI: 10.1111/j.1365-2249.2006.03222.x     Document Type: Article

References (18)

1. Andersen P, Doherty TM. The success and failure of BCG - implications for a novel tuberculosis vaccine. Nat Rev Microbiol 2005; 3:656-62.
2. Brandt L, Cunha JF, Olsen A et al. Failure of the Mycobacterium bovis BCG vaccine. some species of environmental mycobacteria block multiplication of BCG and induction of protective immunity to tuberculosis. Infect Immun 2002; 70:672-8.
3. Buddle BM, Wards BJ, Aldwell FE, Collins DM, de Lisle GW. Influence of sensitization to environmental mycobacteria on subsequent vaccination against bovine tuberculosis. Vaccine 2002; 20:1126-33.
4. Collins FM. Immunogenicity of various mycobacteria and corresponding levels of cross-protection developed between species. Infect Immun 1971; 4:688-96.
5. Edwards ML, Goodrich JM, Muller D, Pollack A, Ziegler JE, Smith DW. Infection with Mycobacterium avium-intracellulare and the protective effects of Bacille Calmette-Guerin. J Infect Dis 1982; 145:733-41.
6. Howard CJ, Kwong LS, Villarreal-Ramos B, Sopp P, Hope JC. Exposure to Mycobacterium avium primes the immune system of calves for vaccination with Mycobacterium bovis BCG. Clin Exp Immunol 2002; 130:190-5.
7. Orme IM, Collins FM. Efficacy of Mycobacterium bovis BCG vaccination inmice undergoing prior pulmonary infection with atypical mycobacteria. Infect Immun 1984; 44:28-32.
8. Palmer CE, Long MW. Effects of infection with atypical mycobacteria on BCG vaccination and tuberculosis. Am Rev Respir Dis 1966; 94:553-68.
9. Weir RE, Fine PEM, Nazareth B et al. Interferon-γ and skin test responses of schoolchildren in southeast England to purified protein derivatives from Mycobacterium tuberculosis and other species of mycobacteria. Clin Exp Immunol 2003; 134:285-94.
10. Black GF, Weir RE, Floyd S et al. BCG-induced increase in interferon-gamma response to mycobacterial antigens and efficacy of BCG vaccination in Malawi and the UK: two randomised controlled studies. Lancet 2002; 359:1393-401.
11. Black GF, Dockrell HM, Crampin AC et al. Patterns and implications of naturally acquired immune responses to environmental and tuberculous mycobacterial antigens in Northern Malawi. J Infect Dis 2001; 184:322-9.
12. Pitulle C, Dorsch M, Kazda J, Wolters J, Stackebrandt E. Phylogeny of rapidly growing members of the genus Mycobacterium. Int J Syst Bacteriol 1992; 42:337-43.
13. Department of Health. Tuberculosis: BCG immunization. In: Salisbury DM, Begg NT, eds. Immunisation against infectious disease, 2nd edn. London: HMSO, 1996:231-2.
14. Sutherland I, Springett VH. Effectiveness of BCG vaccination in England and Wales in 1983. Tubercle 1987; 68:81-92.
15. Karonga Prevention Trial Group. Randomized controlled trial of single BCG, repeated BCG, or combined BCG and killed Mycobacterium leprae vaccine for prevention of leprosy and tuberculosis in Malawi. Lancet 1996; 348:17-24.
16. Orme IM, Collins FM. Crossprotection against nontuberculous mycobacterial infections by Mycobacterium tuberculosis memory immune T lymphocytes. J Exp Med 1986; 163:203-8.
17. Fine PEM, Floyd S, Stanford JL et al. Environmental mycobacteria in northern Malawi: implications for the epidemiology of tuberculosis and leprosy. Epidemiol Infect 2001; 126:379-87.
18. Hart PD, Sutherland I. BCG and vole bacillus vaccines in the prevention of tuberculosis in adolescence and early adult life. BMJ 1977; 22:293-5.